Breaking News on Drug Discovery |
Low volume pipetting is becoming increasingly important for biochemical applications to reduce sample and waste volumes. The Nanopipetting Module from HAMILTON offers a flexible add-on to the STAR line of liquid handling workstations that allows nanoliter and microliter pipetting to be performed on the same platform.
The combination of nanoliter and microliter pipetting saves laboratory space and avoids time-consuming transfers between conventional liquid handling systems and a dedicated nanodispenser. This is particularly valuable for applications such as protein crystallization, compound screening, DNA sequencing or SNP reaction preparation.
HAMILTON's pipetting technology for the microliter range distinguishes itself by providing the option of monitoring each pipetting step using pressure sensors - thus increasing process safety. This high standard of process safety has also been applied to the nanoliter range: the Nanopipetting Module makes use of an integrated miniature flow sensor to monitor the actual dispensed or aspirated volume and to detect clogs in tips.
Thanks to the innovative flow sensor developed by Seyonic, HAMILTON's Nanopipetting Module automatically compensates for any differences or changes in the viscosity of liquids - thus significantly enhancing accuracy and precision. This is important in areas such as protein crystallization, where viscous liquids such as 30% PEG and non-viscous liquids like alcohols need to be accurately handled.
HAMILTON's Nanopipetting Module consists of an 8-channel module with individual control of each channel and 1 or 2 optional independent channels. The module can be combined with various STAR line instrument configurations. The official product launch is scheduled for spring 2006.
11-Jul-2008 - Swedish packaging firm Tetra Pak has acquired the assets of two Australian food processing companies, strengthening its portfolio of solutions for cheese and dairy powder.
14-May-2008 - A petition by drug firm GlaxoSmithKline (GSK) requesting that weight loss claims be treated as disease claims maintains that there is no credible science to back up weight loss ingredients used in dietary supplements.
07-Apr-2008 - Dietary supplements of the omega-3 fatty acid eicosapentaenoic acid (EPA) may ease symptoms associated with depression, suggests a joint Anglo-Iranian study.
01-Feb-2007 - Creatine, the popular nutritional supplement used by athletes to boost performance, may increase muscle strength in people with muscular dystrophies by about nine per cent, says a new review.
05-Jan-2007 - A diet is not just for January. Sure, the wagon-ride to a healthy weight is a bumpy one and some won't manage to cling on. But global government efforts to reduce the impact of the obesity crisis on public health are ongoing, and greater awareness is the cue for the...
26-Sep-2006 - A US Court of Appeals has upheld Kemin Industries' lutein patents after Pigmentos Vegetales del Centro appealed a September 2004 jury verdict - finally closing lengthy litigation between the two parties and giving the Iowa-based ingredients manufacturer security over its intellectual property.
21-Aug-2006 - A review of studies using the herb kava to combat anxiety has reported some positive results and only mild adverse events, giving a much-needed boost to the herb's record despite the need for longer safety and efficacy trials.
30-May-2006 - A New Zealand product development company has announced that PureLo, the company's proprietary Luo Han fruit concentrate, has been affirmed as a GRAS (Generally Regarded As Safe) food ingredient.
18-May-2006 - The role of caffeine in the health of premature and low birth weight babies has come under scrutiny with two studies, one investigating the impact of mothers' intake during pregnancy and the other adding to existing evidence that caffeine can improve the symptoms of apnea in prematurity.
13-Mar-2006 - Supplements of B-vitamins lowered homocysteine levels but did not reduce the risk of heart disease, heart attack or stroke for high-risk patients, report two new studies - findings that cannot be applied to the general population.